Vyking Ventures has entered into a partnership with Dopamine Sports Ventures, a specialized early-stage and growth fund focusing on sports technology. This investment signifies Vyking Ventures' intent to deepen its support for companies at the crossroads of gaming, technology, and innovative player and fan engagement, now extending its focus into the burgeoning sports technology sector via a fund recognized for its substantial industry access.
Originating from a collective of angel investors and professionals within the sports, entertainment, and media realms, Dopamine has established a solid track record through its first self-funded vehicle. The firm is now moving forward with its second fund, designed specifically for early-stage and growth opportunities in sports technology and related fields. Distinctly selective in its investments, Dopamine focuses on integrating operational expertise, industry connections, and strategic guidance from its experienced founding partners.
The fund is headed by founding partners Andreas Meinrad, Barry McNeill, and Markus Egger, who collectively bring decades of experience in sports, entertainment, media, and technology. Dopamine is also cultivating a robust network of entrepreneurs and industry experts from the global sports arena, providing its portfolio companies access to invaluable insights and connections beyond mere financial support.
This investment aligns seamlessly with Vyking's background in iGaming, platform engineering, and crypto-focused infrastructure. Vyking Ventures underscores its belief that successful businesses hinge not only on technological advancements but also on human relationships and industry know-how.
Franz Gerhart, CEO of Vyking, remarked on the collaboration: "Sports and gaming are converging faster than ever, and Dopamine has built exactly the kind of network and hands-on operating experience we look for in a partner. We’re proud to back Dopamine and look forward to supporting its portfolio companies as they scale."
Markus Egger, a founding partner at Dopamine, expressed enthusiasm for the partnership: "We’re excited and grateful to welcome Franz, and the wider Vyking Ventures team, as investors in Dopamine. We’ve already seen the depth of expertise and network they bring to the group. However sophisticated the tools and technology in this industry become, we remain convinced that human connections built on trust will keep being one of the most important success factors in the world of investing."
With this investment, Vyking Ventures aims to bolster Dopamine's growth, support emerging sports technology founders, and expand its network throughout the international sports sector.
